GOLDILOCKS THERAPEUTICS
Goldilocks Therapeutics develop preventatives treatments for acute kidney injury, polycystic kidney disease, and other kidney conditions. The company uses its proprietary mesoscale nanoparticles (MNPs) specifically target therapeutic payloads to the renal tubule epithelium. It was founded in 2018 and is based in Bedford, New York.
GOLDILOCKS THERAPEUTICS
Industry:
Health Care Health Diagnostics Medical Wellness
Founded:
2018-01-01
Address:
Bedford, New York, United States
Country:
United States
Website Url:
http://www.goldilockstherapeutics.com
Total Employee:
1+
Status:
Active
Contact:
(914) 205-3862
Total Funding:
0
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress
Current Employees Featured
Founder
Investors List
Accelerate New York Seed Fund
Accelerate New York Seed Fund investment in Seed Round - Goldilocks Therapeutics
Official Site Inspections
http://www.goldilockstherapeutics.com Semrush global rank: 5.82 M Semrush visits lastest month: 1.43 K
- Host name: 104.21.80.3
- IP address: 104.21.80.3
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Goldilocks Therapeutics"
Goldilocks Therapeutics - Org Chart, Teams, Culture
View Goldilocks Therapeutics' up-to-date org chart, open roles, and culture details. Find executives, board members, teams, related companies, and more.See details»
Goldilocks Therapeutics - Crunchbase Company Profile …
Goldilocks Therapeutics develop preventatives treatments for acute kidney injury, polycystic kidney disease, and other kidney conditions.See details»
Goldilocks Therapeutics - Overview, News & Similar companies
View Goldilocks Therapeutics (www.goldilockstherapeutics.com) location in New York, United States , revenue, industry and description. Find related and similar companies as well as …See details»
Goldilocks Therapeutics 2025 Company Profile: …
Information on valuation, funding, cap tables, investors, and executives for Goldilocks Therapeutics. Use the PitchBook Platform to explore the full profile.See details»
Goldilocks Therapeutics - Products, Competitors, Financials, …
About Goldilocks Therapeutics Goldilocks Therapeutics develops preventatives and treatments for acute kidney injury (AKI), chronic kidney disease (CKD), polycystic kidney disease (PKD), and …See details»
Goldilocks Therapeutics Company Profile | Management and
Find contact information for Goldilocks Therapeutics. Learn about their Pharmaceuticals, Manufacturing market share, competitors, and Goldilocks Therapeutics's email format.See details»
Goldilocks Therapeutics, Inc. - Drug pipelines, Patents, Clinical ...
May 8, 2025 Explore Goldilocks Therapeutics, Inc. with its drug pipeline, therapeutic area, technology platform, 1 news, and 2 literature.See details»
Goldilocks Therapeutics, Inc. Company Profile | Bedford, NY ...
Find company research, competitor information, contact details & financial data for Goldilocks Therapeutics, Inc. of Bedford, NY. Get the latest business insights from Dun & Bradstreet.See details»
Goldilocks Therapeutics - VentureRadar
Dansk Biotek Unknown n/a DANISH BIOTECH is a trade organization for Danish biotech companies with the aim to promote opportunities for biotechnology research, development and …See details»
Goldilocks Therapeutics, Inc. · 55 East Field Drive, Bedford, NY 10506
GOLDILOCKS THERAPEUTICS, INC. (DOS #5324758) is a Foreign Business Corporation in Bedford registered with the New York State Department of State (NYSDOS). The business …See details»
Goldilocks Therapeutics, Inc. - CAGE.report
Organization, Ownership & Certifications Legal Structure: Ownership and Self-Certifications:See details»
Goldilocks Therapeutics | VentureRadar
DANISH BIOTECH is a trade organization for Danish biotech companies with the aim to promote opportunities for biotechnology research, development and production in Denmark and …See details»
Goldilocks Therapeutics, Inc. - CMOCRO
Goldilocks Therapeutics was formed to develop preventatives and/or treatments for acute kidney injury (AKI), polycystic kidney disease (PKD), and other under-treated kidney conditions by …See details»
Goldilocks Therapeutics - Profiles & Contacts - Crunchbase
Goldilocks Therapeutics develop preventatives treatments for acute kidney injury, polycystic kidney disease, and other kidney conditions.See details»
EIN 82-5080202 - Goldilocks Therapeutics, Inc., Bedford, New York
Goldilocks Therapeutics, Inc. is a corporation in Bedford, New York. The employer identification number (EIN) for Goldilocks Therapeutics, Inc. is 825080202. EIN for organizations is …See details»
Arthur Klausner - ELabNYC
Arthur Klausner is CEO of Goldilocks Therapeutics, Inc., a start-up focused on targeted renal drug delivery, initially to prevent/treat acute kidney injury. He was previously CEO of Gem …See details»
Goldilocks Therapeutics - Financial Details - Crunchbase
Goldilocks Therapeutics has raised 1 round.This was a Seed round raised on Jan 1, 2020. Which funding types raised the most money? How much funding has this organization raised over time?See details»
Goldilocks Therapeutics - Funding, Financials, Valuation & Investors
Goldilocks Therapeutics develop preventatives treatments for acute kidney injury, polycystic kidney disease, and other kidney conditions.See details»
Goldilocks Therapeutics, Inc. | SBIR.gov
PROJECT SUMMARY Acute kidney injury (AKI) is a common clinical condition associated with increased morbidity and mortality. AKI accounts for approximately 2% of hospital admissions …See details»
Goldilocks Therapeutics - News & Analysis - Crunchbase
Goldilocks Therapeutics develop preventatives treatments for acute kidney injury, polycystic kidney disease, and other kidney conditions.See details»